Authors:
Roth, AD
Maibach, R
Martinelli, G
Fazio, N
Aapro, MS
Pagani, O
Morant, R
Borner, MM
Herrmann, R
Honegger, H
Cavalli, F
Alberto, P
Castiglione, M
Goldhirsch, A
Citation: Ad. Roth et al., Docetaxel (Taxotere (R))-cisplatin (TC): An effective drug combination in gastric carcinoma, ANN ONCOL, 11(3), 2000, pp. 301-306
Authors:
Douillard, JY
Cunningham, D
Roth, AD
Navarro, M
James, RD
Karasek, P
Jandik, P
Iveson, T
Carmichael, J
Alakl, M
Gruia, G
Awad, L
Rougier, P
Citation: Jy. Douillard et al., Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial, LANCET, 355(9209), 2000, pp. 1041-1047
Authors:
Roth, AD
Berney, CR
Rohner, S
Allal, AS
Morel, P
Marti, MC
Aapro, MS
Alberto, P
Citation: Ad. Roth et al., Intra-arterial chemotherapy in locally advanced or recurrent carcinomas ofthe penis and anal canal: an active treatment modality with curative potential, BR J CANC, 83(12), 2000, pp. 1637-1642
Citation: Ad. Roth et al., High dose etretinate and interferon-alpha - A phase I study in squamous cell carcinomas and transitional cell carcinomas, ACTA ONCOL, 38(5), 1999, pp. 613-617
Authors:
Allal, AS
Obradovic, M
Laurencet, F
Roth, AD
Spada, A
Marti, MC
Kurtz, JM
Citation: As. Allal et al., Treatment of anal carcinoma in the elderly - Feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy, CANCER, 85(1), 1999, pp. 26-31
Authors:
Roth, AD
Herrmann, R
Morant, R
Borner, MM
Honegger, HP
Obrist, R
Bacchi, M
Lange, J
Alberto, P
Castiglione, M
Citation: Ad. Roth et al., Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: The SAKK experience, EUR J CANC, 34(13), 1998, pp. 2126-2128